European Stroke Organisation (ESO)-European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion

Standard

European Stroke Organisation (ESO)-European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion. / Turc, Guillaume; Tsivgoulis, Georgios; Audebert, Heinrich J; Boogaarts, Hieronymus; Bhogal, Pervinder; De Marchis, Gian Marco; Fonseca, Ana Catarina; Khatri, Pooja; Mazighi, Mikaël; Pérez de la Ossa, Natalia; Schellinger, Peter D; Strbian, Daniel; Toni, Danilo; White, Philip; Whiteley, William; Zini, Andrea; van Zwam, Wim; Fiehler, Jens.

in: J NEUROINTERV SURG, Jahrgang 14, Nr. 3, 03.2022, S. 209-227.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Turc, G, Tsivgoulis, G, Audebert, HJ, Boogaarts, H, Bhogal, P, De Marchis, GM, Fonseca, AC, Khatri, P, Mazighi, M, Pérez de la Ossa, N, Schellinger, PD, Strbian, D, Toni, D, White, P, Whiteley, W, Zini, A, van Zwam, W & Fiehler, J 2022, 'European Stroke Organisation (ESO)-European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion', J NEUROINTERV SURG, Jg. 14, Nr. 3, S. 209-227. https://doi.org/10.1136/neurintsurg-2021-018589

APA

Turc, G., Tsivgoulis, G., Audebert, H. J., Boogaarts, H., Bhogal, P., De Marchis, G. M., Fonseca, A. C., Khatri, P., Mazighi, M., Pérez de la Ossa, N., Schellinger, P. D., Strbian, D., Toni, D., White, P., Whiteley, W., Zini, A., van Zwam, W., & Fiehler, J. (2022). European Stroke Organisation (ESO)-European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion. J NEUROINTERV SURG, 14(3), 209-227. https://doi.org/10.1136/neurintsurg-2021-018589

Vancouver

Bibtex

@article{2175e01db1834727838022b864dbd843,
title = "European Stroke Organisation (ESO)-European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion",
abstract = "Six randomized controlled clinical trials have assessed whether mechanical thrombectomy (MT) alone is non-inferior to intravenous thrombolysis (IVT) plus MT within 4.5 hours of symptom onset in patients with anterior circulation large vessel occlusion (LVO) ischemic stroke and no contraindication to IVT. An expedited recommendation process was initiated by the European Stroke Organisation (ESO) and conducted with the European Society of Minimally Invasive Neurological Therapy (ESMINT) according to ESO standard operating procedure based on the GRADE system. We identified two relevant Population, Intervention, Comparator, Outcome (PICO) questions, performed systematic reviews and meta-analyses of the literature, assessed the quality of the available evidence, and wrote evidence-based recommendations. Expert opinion was provided if insufficient evidence was available to provide recommendations based on the GRADE approach.For stroke patients with anterior circulation LVO directly admitted to a MT-capable center ('mothership') within 4.5 hours of symptom onset and eligible for both treatments, we recommend IVT plus MT over MT alone (moderate evidence, strong recommendation). MT should not prevent the initiation of IVT, nor should IVT delay MT. In stroke patients with anterior circulation LVO admitted to a center without MT facilities and eligible for IVT ≤4.5 hours and MT, we recommend IVT followed by rapid transfer to a MT capable-center ('drip-and-ship') in preference to omitting IVT (low evidence, strong recommendation). Expert consensus statements on ischemic stroke on awakening from sleep are also provided. Patients with anterior circulation LVO stroke should receive IVT in addition to MT if they have no contraindications to either treatment.",
keywords = "Brain Ischemia/drug therapy, Fibrinolytic Agents/therapeutic use, Humans, Ischemic Stroke, Mechanical Thrombolysis/methods, Stroke/drug therapy, Thrombectomy/methods, Thrombolytic Therapy/methods, Treatment Outcome",
author = "Guillaume Turc and Georgios Tsivgoulis and Audebert, {Heinrich J} and Hieronymus Boogaarts and Pervinder Bhogal and {De Marchis}, {Gian Marco} and Fonseca, {Ana Catarina} and Pooja Khatri and Mika{\"e}l Mazighi and {P{\'e}rez de la Ossa}, Natalia and Schellinger, {Peter D} and Daniel Strbian and Danilo Toni and Philip White and William Whiteley and Andrea Zini and {van Zwam}, Wim and Jens Fiehler",
note = "{\textcopyright} Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.",
year = "2022",
month = mar,
doi = "10.1136/neurintsurg-2021-018589",
language = "English",
volume = "14",
pages = "209--227",
journal = "J NEUROINTERV SURG",
issn = "1759-8478",
publisher = "BMJ PUBLISHING GROUP",
number = "3",

}

RIS

TY - JOUR

T1 - European Stroke Organisation (ESO)-European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion

AU - Turc, Guillaume

AU - Tsivgoulis, Georgios

AU - Audebert, Heinrich J

AU - Boogaarts, Hieronymus

AU - Bhogal, Pervinder

AU - De Marchis, Gian Marco

AU - Fonseca, Ana Catarina

AU - Khatri, Pooja

AU - Mazighi, Mikaël

AU - Pérez de la Ossa, Natalia

AU - Schellinger, Peter D

AU - Strbian, Daniel

AU - Toni, Danilo

AU - White, Philip

AU - Whiteley, William

AU - Zini, Andrea

AU - van Zwam, Wim

AU - Fiehler, Jens

N1 - © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2022/3

Y1 - 2022/3

N2 - Six randomized controlled clinical trials have assessed whether mechanical thrombectomy (MT) alone is non-inferior to intravenous thrombolysis (IVT) plus MT within 4.5 hours of symptom onset in patients with anterior circulation large vessel occlusion (LVO) ischemic stroke and no contraindication to IVT. An expedited recommendation process was initiated by the European Stroke Organisation (ESO) and conducted with the European Society of Minimally Invasive Neurological Therapy (ESMINT) according to ESO standard operating procedure based on the GRADE system. We identified two relevant Population, Intervention, Comparator, Outcome (PICO) questions, performed systematic reviews and meta-analyses of the literature, assessed the quality of the available evidence, and wrote evidence-based recommendations. Expert opinion was provided if insufficient evidence was available to provide recommendations based on the GRADE approach.For stroke patients with anterior circulation LVO directly admitted to a MT-capable center ('mothership') within 4.5 hours of symptom onset and eligible for both treatments, we recommend IVT plus MT over MT alone (moderate evidence, strong recommendation). MT should not prevent the initiation of IVT, nor should IVT delay MT. In stroke patients with anterior circulation LVO admitted to a center without MT facilities and eligible for IVT ≤4.5 hours and MT, we recommend IVT followed by rapid transfer to a MT capable-center ('drip-and-ship') in preference to omitting IVT (low evidence, strong recommendation). Expert consensus statements on ischemic stroke on awakening from sleep are also provided. Patients with anterior circulation LVO stroke should receive IVT in addition to MT if they have no contraindications to either treatment.

AB - Six randomized controlled clinical trials have assessed whether mechanical thrombectomy (MT) alone is non-inferior to intravenous thrombolysis (IVT) plus MT within 4.5 hours of symptom onset in patients with anterior circulation large vessel occlusion (LVO) ischemic stroke and no contraindication to IVT. An expedited recommendation process was initiated by the European Stroke Organisation (ESO) and conducted with the European Society of Minimally Invasive Neurological Therapy (ESMINT) according to ESO standard operating procedure based on the GRADE system. We identified two relevant Population, Intervention, Comparator, Outcome (PICO) questions, performed systematic reviews and meta-analyses of the literature, assessed the quality of the available evidence, and wrote evidence-based recommendations. Expert opinion was provided if insufficient evidence was available to provide recommendations based on the GRADE approach.For stroke patients with anterior circulation LVO directly admitted to a MT-capable center ('mothership') within 4.5 hours of symptom onset and eligible for both treatments, we recommend IVT plus MT over MT alone (moderate evidence, strong recommendation). MT should not prevent the initiation of IVT, nor should IVT delay MT. In stroke patients with anterior circulation LVO admitted to a center without MT facilities and eligible for IVT ≤4.5 hours and MT, we recommend IVT followed by rapid transfer to a MT capable-center ('drip-and-ship') in preference to omitting IVT (low evidence, strong recommendation). Expert consensus statements on ischemic stroke on awakening from sleep are also provided. Patients with anterior circulation LVO stroke should receive IVT in addition to MT if they have no contraindications to either treatment.

KW - Brain Ischemia/drug therapy

KW - Fibrinolytic Agents/therapeutic use

KW - Humans

KW - Ischemic Stroke

KW - Mechanical Thrombolysis/methods

KW - Stroke/drug therapy

KW - Thrombectomy/methods

KW - Thrombolytic Therapy/methods

KW - Treatment Outcome

U2 - 10.1136/neurintsurg-2021-018589

DO - 10.1136/neurintsurg-2021-018589

M3 - SCORING: Journal article

C2 - 35115395

VL - 14

SP - 209

EP - 227

JO - J NEUROINTERV SURG

JF - J NEUROINTERV SURG

SN - 1759-8478

IS - 3

ER -